Jon Jones tests positive for 'abnormal metabolite: Gustavson fight scrapped temporarily

On Sunday, shocking news broke that UFC 232 will be moved from Las Vegas to Los Angeles after the Nevada Athletic Commission refused to license Jones for next Saturday’s light heavyweight championship main event bout with Alexander Gustafsson. A recent urine sample collected from the UFC star led to a “drug-testing abnormality” and he will be required to appear before the NAC again in January before he is eligible to compete in Nevada again.

The NAC will not license Jones to fight Alexander Gustafsson on Dec. 29 due to a drug-testing abnormality. Per a statement from the commission, after analysis of 18 months of Jones drug-test results, the NAC has determined that Jones will have to come before the commission for a hearing in January. He will not be able to fight next weekend.

“This will allow for a measured, thoughtful, and comprehensive discussion of his anti-doping testing protocol and results and provide an opportunity for the NSAC to determine the appropriate path forward for him in Nevada,” the commission statement read. “We look forward to his hearing.”

The UFC will not cancel the light heavyweight title fight. Jones will still fight Gustafsson, as UFC 232 moves to Inglewood, Calif. The California State Athletic Commission (CSAC) has already granted Jones a license. CSAC executive officer Andy Foster told MMA Fighting that the abnormality in Jones’ test results comes from his positive drug test back in July 2017. Jones was suspended 15 months for that failed test for a steroid metabolite.